Pharmacologic Management of Pediatric Hypertension

dc.contributor.authorMisurac, Jason
dc.contributor.authorNichols, Kristen R.
dc.contributor.authorWilson, Amy C.
dc.contributor.departmentDepartment of Pediatrics, IU School of Medicineen_US
dc.date.accessioned2016-11-04T15:30:13Z
dc.date.available2016-11-04T15:30:13Z
dc.date.issued2016-02
dc.description.abstractHypertension in children is common, and the prevalence of primary hypertension is increasing with the obesity epidemic and changing dietary choices. Careful measurement of blood pressure is important to correctly diagnose hypertension, as many factors can lead to inaccurate blood pressure measurement. Hypertension is diagnosed based on comparison of age-, sex-, and height-based norms with the average systolic and diastolic blood pressures on three separate occasions. In the absence of hypertensive target organ damage (TOD), stage I hypertension is managed first by diet and exercise, with the addition of drug therapy if this fails. First-line treatment of stage I hypertension with TOD and stage II hypertension includes both lifestyle changes and medications. First-line agents include angiotensin-converting enzyme (ACE) inhibitors, thiazide diuretics, and calcium-channel blockers. Hypertensive emergency with end-organ effects requires immediate modest blood pressure reduction to alleviate symptoms. This is usually accomplished with IV medications. Long-term reduction in blood pressure to normal levels is accomplished gradually. Specific medication choice for outpatient hypertension management is determined by the underlying cause of hypertension and the comparative adverse effect profiles, along with practical considerations such as cost and frequency of administration. Antihypertensive medication is initiated at a starting dose and can be gradually increased to effect. If ineffective at the recommended maximum dose, an additional medication with a complementary mechanism of action can be added.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationMisurac, J., Nichols, K. R., & Wilson, A. C. (2016). Pharmacologic Management of Pediatric Hypertension. Pediatric Drugs, 18(1), 31–43. http://doi.org/10.1007/s40272-015-0151-3en_US
dc.identifier.urihttps://hdl.handle.net/1805/11379
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s40272-015-0151-3en_US
dc.relation.journalPediatric Drugsen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectpediatric hypertensionen_US
dc.subjecthypertension managementen_US
dc.titlePharmacologic Management of Pediatric Hypertensionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Misurac_2016_pharmacologic.pdf
Size:
280.8 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: